Circulating androgen levels and self-reported sexual function in women

JAMA

Volumn 294, Issue 1, 2005, Pages 91-96

  Davis, Susan R ^a,b,e   Davison, Sonia L ^b,c   Donath, Susan ^a,d   Bell, Robin J ^a,b  

^a ALFRED HOSPITAL   (Australia)

^b Jean Hailes Foundation for Women's Health   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; PRASTERONE; TESTOSTERONE; PRASTERONE SULFATE;

ADULT; AGED; ANDROGEN BLOOD LEVEL; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; BLOOD ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HUMAN; LIBIDO; MAJOR CLINICAL STUDY; PATIENT SELECTION; PRIORITY JOURNAL; SELF REPORT; SEXUAL AROUSAL; SEXUAL BEHAVIOR; SEXUAL FUNCTION; STATISTICAL SIGNIFICANCE; TESTOSTERONE BLOOD LEVEL; ADOLESCENT; BLOOD; MIDDLE AGED; PHYSIOLOGY; ROC CURVE; SEXUAL DYSFUNCTION;

ADOLESCENT; ADULT; AGED; ANDROSTENEDIONE; DEHYDROEPIANDROSTERONE SULFATE; FEMALE; HUMANS; LIBIDO; MIDDLE AGED; ROC CURVE; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; TESTOSTERONE;

EID: 21444459581     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.294.1.91     Document Type: Article

References (29)

1. Béjin A. Sexual pleasures, dysfunctions, fantasies, and satisfaction. In: Spira AB, ed. Sexual Behaviour and AIDS. Aldershot, England: Avebury; 1994:163-171.
2. Kontula O, Haavio-Mannila E. Sexual pleasures. In: Enhancement of Sex Life in Finland, 1971-1992. Aldershot, England: Dartmouth; 1995.
3. Laumann E, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA. 1999;281:537-544.
4. Nathorst-Boos J, von Schoultz H. Psychological reactions and sexual life after hysterectomy with and without oophorectomy. Gynecol Obstet Invest. 1992;34:97-101.
5. Dennerstein L, Dudley EC, Hopper JL, Burger H. Sexuality, hormones and the menopausal transition. Maturitas. 1997;26:83-93.
6. Bachmann GA, Bancroft J, Braunstein G, et al. Female androgen insufficiency: the Princeton consensus statement on definition, classification and assessment. Fertil Steril. 2002;77:660-665.
7. Miller KK, Rosner W, Lee H, et al. Measurement of free testosterone in normal women and women with androgen deficiency: comparison of methods. J Clin Endocrinol Metab. 2004;89:525-533.
8. Davis SR, McCloud PI, Strauss BJG, Burger HG. Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality. Maturitas. 1995;21:227-236.
9. Shifren JL, Braunstein G, Simon J, et al. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med. 2000;343:682-688.
10. Goldstat R, Briganti E, Tran J, Wolfe R, Davis S. Transdermal testosterone improves mood, well being and sexual function in premenopausal women. Menopause. 2003;10:390-398.
11. Sherwin BB, Gelfand MM. The role of androgen in the maintenance of sexual functioning in oophorectomized women. Psychosom Med. 1987;49:397-409.
12. Cameron DR, Braunstein GD. Androgen replacement therapy in women. Fertil Steril. 2004;82:273-289.
13. McHorney CA, Rust J, Golombok S, et al. Profile of female sexual function: a patient-based, international, psychometric instrument for the assessment of hypoactive sexual desire in oophorectomized women. Menopause. 2004;11:474-483.
14. Derogatis L, Rust J, Golombok S, et al. Validation of the Profile of Female Sexual Function (PFSF) in surgically and naturally menopausal women. J Sex Marital Ther. 2004;30:25-36.
15. Sinha-Hakim I, Arver S, Beall G, et al. The use of a sensitive equilibrium dialysis method for the measurement of free testosterone levels in healthy, cycling women and in human immunodeficiency virus-infected women. J Clin Endocrinol Metab. 1998;83:1312-1318.
16. Goebelsmann U, Arce J, Thorneycroft L, Mishell D Jr. Serum testosterone concentrations in women throughout the menstrual cycle and following HCG administration. Am J Obstet Gynecol. 1974;119:445-452.
17. Chen C, Weiss NS, Stanczyk FZ, et al. Endogenous sex hormones and prostate cancer risk: a casecontrol study nested within the Carotene and Retinol Efficacy Trial. Cancer Epidemiol Biomarkers Prev. 2003;12:1410-1416.
18. Lamar CA, Dorgan JF, Longcope C, Stanczyk FZ, Falk RT, Stephenson HE Jr. Serum sex hormones and breast cancer risk factors in postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2003;12:380-383.
19. Sodergard R, Backstrom T, Shanhag V, Carstensen H. Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature. J Steroid Biochem. 1982;16:801-810.
20. Zumoff B, Strain GW, Miller LK, Rosner W. Twenty-four hour mean plasma testosterone concentration declines with age in normal premenopausal women. J Clin Endocrinol Metab. 1995;80:1429-1430.
21. Burger HG, Dudley EC, Cui J, Dennerstein L, Hooper J. A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition. J Clin Endocrinol Metab. 2000;85:2832-2838.
22. Davison S, Bell R, Donath S, Montalto J, Davis S. Androgen levels in adult females: changes with age, menopause and oophorectomy. J Clin Endocrinol Metab. In press.
23. Hanley J, McNeil B. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143:29-36.
24. Burger HG. Androgen production in women. Fertil Steril. 2002;77(suppl 4):S3-S5.
25. Labrie F, Luu-The V, Labrie C, et al. Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone. Endocr Rev. 2003;24:152-182.
26. Labrie F, Belanger A, Luu-The V, et al. DHEA and the intracrine formation of androgens and estrogens in peripheral target tissues: its role during aging. Steroids. 1998;63:322-328.
27. Agarwal VR, Ashanullah C, Simpson ER, Bulun S. Alternatively spliced transcripts of the aromatase cytochrome P450 (CYP19) gene in adipose tissue of women. J Clin Endocrinol Metab. 1997;82:70-74.
28. Labrie F. Intracrinology. Mol Cell Endocrinol. 1991;78:C113-C118.
29. Labrie F, Belanger A, Cusan L, Candas B. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology. J Clin Endocrinol Metab. 1997;82:2403-2409.